<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48656">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01994928</url>
  </required_header>
  <id_info>
    <org_study_id>PV-4429</org_study_id>
    <nct_id>NCT01994928</nct_id>
  </id_info>
  <brief_title>Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High-flow Nasal Cannula Oxygen.</brief_title>
  <official_title>Prospective Randomised Study on Preoxygenation in the Intensive Care Unit Using a Nose-mouth Mask Versus High Flow Nasal Cannula Oxygen.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universit채tsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universit채tsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoxygenation is routinely performed before endotracheal intubation. In the intensive care
      unit, preoxygenation is often accomplished using a nose-mouth mask. It seems probable that
      high flow nasal cannula oxygen, which is used in the treatment of patients with hypoxemic
      respiratory failure, is equally effective in preventing the development of hypoxemia during
      intubation. In this prospective randomized study preoxygenation using high flow nasal
      cannula oxygen is compared with preoxygenation via nose-mouth mask in patients with
      hypoxemic respiratory failure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Mean decrease in the saturation of oxygen (SpO2) during intubation.</measure>
    <time_frame>during intubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in blood gases after intubation.</measure>
    <time_frame>30 minutes after intubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in hemodynamics.</measure>
    <time_frame>during intubation and up to 30 minutes after intubation</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Nose-mouth mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Performance of intubation after preoxygenation using a nose-mouth mask.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High flow nasal cannula oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Performance of intubation after preoxygenation using high flow nasal cannula oxygen.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nose-mouth mask</intervention_name>
    <description>Preoxygenation using a nose-mouth mask.</description>
    <arm_group_label>Nose-mouth mask</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High flow nasal cannula oxygen</intervention_name>
    <description>Preoxygenation using high flow nasal cannula oxygen.</description>
    <arm_group_label>High flow nasal cannula oxygen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intubation</intervention_name>
    <description>Intubation</description>
    <arm_group_label>Nose-mouth mask</arm_group_label>
    <arm_group_label>High flow nasal cannula oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients treated in an intensive care unit

          -  indication for intubation

          -  presence of hypoxemic (SaO2/fraction of inspired oxygen(FiO2): 300 or less)
             respiratory failure

          -  informed consent

        Exclusion Criteria:

          -  blocked nasopharynx

          -  contraindications for nose-mouth mask or high flow nasal cannula oxygen

          -  expected difficult airway
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan Kluge, MD</last_name>
    <phone>+49-40-7410-57010</phone>
    <email>skluge@uke.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universit채tsklinikum Hamburg-Eppendorf, Department of Intensive Care Medicine</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Kluge, MD</last_name>
      <phone>+49-40-7410-57010</phone>
      <email>skluge@uke.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Kluge, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Frings, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 20, 2013</lastchanged_date>
  <firstreceived_date>November 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universit채tsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Stefan Kluge</investigator_full_name>
    <investigator_title>PD Dr. Stefan Kluge</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
